Notch proteins function as receptors for membrane-bound ligands (Jagged and Delta-like) to regulate cell-fate determination. We have investigated the role of Notch signaling in embryonic endothelium of the mouse by expressing an activated form of the Notch4 protein in vasculature under the regulation of the Flk1 (VEGFR) locus. Expression of activated Notch4 results in a growth and developmental delay and embryonic lethality at about 10 days postcoitum. The extent of the developing vasculature in mutant embryos was restricted, fewer small vessels were seen, and vascular networks were disorganized. The brain periphery of mutant embryos contained large dilated vessels with evidence of compromised vessel-wall integrity and large areas of necrosis; yolk-sac vasculature was abnormal. Expression of an activated form of Notch4 in embryonic vasculature leads to abnormal vessel structure and patterning, implicating the Notch pathway in phases of vascular development associated with vessel patterning and remodeling.
Notch ͉ Flk1 ͉ Jagged1 ͉ vasculature F ormation of the vascular system begins early in mammalian development, with the specification and aggregation of angiogenic precursors in the embryo and formation of blood islands in the visceral yolk sac. In the yolk sac, there is a close association between the primitive hematopoietic cells and the developing endothelium, suggestive of a common precursor, the so-called hemangioblast (1) . Within the embryo itself, the first blood vessels develop in the absence of hematopoiesis, suggesting that these precursors are solely angiogenic (2) . The early blood vessels of the embryo or the yolk sac develop by aggregation of angioblasts that form de novo into a primitive network of simple endothelial tubes-the process of vasculogenesis (3) . Later development of the mature vessel system involves a complex process of remodeling and refining the initial pattern, with the proliferation and sprouting of new vessels from existing ones-the process of angiogenesis (3) .
Full elaboration of the vascular system is more complex than what is suggested by this division into two phases. As vessels begin to be remodeled into a functioning circulation system, they need to undergo localized proliferation and regression as well as programmed branching and migration. They must be specified into different calibers and types of vessels, including divisions into arteries, veins, and lymphatics, with separate subdivisions into large vessels, venules, arterioles, and capillaries. In addition, vessels must recruit supporting cells, smooth muscle cells, and pericytes (4) to ensure the stability of the vessels formed.
A number of signaling pathways, such as VEGF͞VEGFR (vascular endothelial growth factor and its receptor) and Angiopoietin͞Tie, are involved in vascular development. VEGF signaling plays a major role in promoting the proliferation and differentiation of the endothelial lineage from the earliest stages of development, whereas the Angiopoietin͞Tie pathway acts slightly later to promote the recruitment of supporting cells and vessel stabilization (5) . However, the action of these factors alone is not sufficient to explain the complex patterning of the developing vasculature. There is growing evidence for specific vascular roles for the components of other signaling pathways, including the Ephrin͞Eph, TGF-␤ (transforming growth factor ␤), PDGF (platelet-derived growth factor), FGF (fibroblast growth factor), and Delta͞Notch pathways.
The Delta͞Notch pathway was originally characterized in Drosophila (6) . This pathway is conserved through evolution from Caenorhabditis elegans (7) to humans (8, 9) . Notch signaling is often associated with the promotion of a stem cell vs. differentiated cell fate (10) as, for example, in primary neurogenesis (11) or during T cell development (12) . However, it is also involved in patterning processes in development, including lateral inhibition of cell-fate choices at both a single-cell level and at a group-decision level. In other situations, Notch signaling acts in a more classically inductive manner to regulate cell-fate decisions.
Several Notch receptors and ligands are expressed in the developing vasculature, and Notch4 is restricted in expression to this lineage in mouse embryos (9, 13) . Notch4 expression has been detected as early as 7.5 days postcoitum (dpc) by reverse transcription-PCR (RT-PCR), and whole-mount in situ analysis has shown endothelial-specific expression of Notch4 throughout embryogenesis in a pattern similar to that observed for Flk1 (13) . A Notch ligand, Delta-like 4 (Dll4), is expressed in arterial endothelium and can function as a ligand for both Notch1 and Notch4 (14) . Genetic evidence supports a role for Notch signaling in vascular development in both mice and humans. Mouse mutations in Notch ligands, Delta1 and Jagged1, cause vascular problems-hemorrhaging in Dll1 mutants (15) and vascular-remodeling defects in Jagged1 mutants (16) . Mutation of the presenilin 1 (PS1) gene, proposed to be involved in Notch signaling, produces a complex phenotype and shows extensive hemorrhaging (17, 18) . A Notch1͞Notch4 double mutant has been generated and results in embryonic lethality with severe defects in angiogenic vascular remodeling (19) ; a similar phenotype is seen in Notch1 mutant embryos (19) . Expression of activated Notch4 or Jagged1 can promote the differentiation of cultured endothelial cells into vessel-like structures (20) . The most compelling evidence that Notch genes are involved in human vascular disorders comes from an analysis of a human disorder termed CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephelopathy) which is manifested by stroke and vascular dementia and characterized by arteriopathy of cerebral arterioles. Mutations in human Notch3 have been characterized in CADASIL patients (21) .
It is not clear from mutants whether the Notch signaling pathway acts autonomously in the endothelium, because all of the mutated genes show expression in many different cell types, nor is it clear what phase of vascular development depends on Notch signaling. Addressing these issues requires endothelial-specific manipulation of Notch function. In both flies and worms, Notch functions have been defined by the opposite phenotypes of loss-of-function and constitutively activated Notch mutations (22) . Here, we investigate the role of Notch signaling in the mammalian endothelium by expressing an activated form of the Notch4 protein in endothelial cells under the regulation of the Flk1 (VEGFR) locus. This expression resulted in embryonic lethality, associated with abnormal vessel structure and vascular patterning, implicating the activity of the Notch pathway in the later phases of vascular development but not in the initial specification of the lineage.
Materials and Methods
Production of Flk1͞int-3HA Embryonic Stem (ES) Cells. A targeting vector was constructed that inserts int-3HA [the activated Notch4, hemagglutinin epitope (HA)-tagged at the carboxyl terminus], with a simian virus 40 poly(A) signal, in place of lacZ sequences in the previously generated Flk1 targeting vector (23) . The backbone of the vector is pPNTloxP, containing PGKneo (flanked by two loxP sites) for positive selection and PGK-TK for negative selection. int-3HA is inserted in the 5Ј untranslated region of Flk1 and contains its own translational initiation signal. This construct was electroporated into Tie1 ϩ/Ϫ ES cells, and correctly targeted clones (Flk1͞int-3) were positively selected for by using G418 and negatively selected for by using ganciclovir. Tie1 ϩ/Ϫ ES cells in which one allele of the Tie1 gene is replaced by the lacZ gene were used. Thus, targeted ES-cell clones express Notch͞int-3 under control of the Flk1 promoter and express lacZ under control of the Tie1 promoter. The expression of ␤-galactosidase was used as a marker for endothelial cells. Southern blot hybridization determined that ES-cell clones had one Flk1 allele replaced with Notch4͞int-3 by homologous recombination (Fig. 1) .
Generation of Flk1͞int-3 ES Embryos. ES-cell lines were used in aggregations with tetraploid inner cell mass embryos. Two-cell diploid embryos were fused to become tetraploid one-cell embryos, cultured to the four-cell stage, and then aggregated with ES cells. Composite embryos were cultured overnight and then transferred to pseudopregnant recipients. Embryos that were entirely Flk1͞int-3 and control Tie1-lacZ-derived embryos were generated by using the technique described above.
␤-Galactosidase Staining. Embryos were dissected at various stages, fixed, stained for lacZ expression, and counterstained as previously described (23) .
Whole-Mount RNA in Situ Hybridization and Antibody Staining.
Digoxigenin-labeled RNA probes were transcribed from linearized templates and whole-mount in situ hybridization was carried out as described (24) .
␣-Smooth muscle actin (SMA) antibody (Clone 1A4) was obtained from Sigma, and the Tek͞Tie2 antibody was kindly provided by N. Takakura (Kumamoto University School of Medicine, Kumamoto, Japan) (25) . Whole-mount antibody staining was performed as described (26) .
In Vitro Differentiation of ES Cells. ES cells were allowed to differentiate into cystic EBs in vitro (27) . ES cells were passaged twice in the presence of lymphocyte inhibitory factor (LIF) on gelatincoated plates. On day 6, after the second passage, ES colonies were treated with dispase, washed, and grown in suspension in bacterial dishes in ES medium without LIF. On day 8 after the dispase treatment, ␤-galactosidase activity was detected as described.
RT-PCR. Poly(A)
ϩ RNA from mouse kidney and EBs generated from either control ID5 ES-cell line or the targeted ES-cell line 1A12 was analyzed by RT-PCR. RT-PCR was performed with Robocycler (Stratagene). For the expression analysis of Notch4, Notch3, Tie1, and the int-3HA transgene, specific primers were used to amplify fragments by using equal amounts of cDNA. Primer sequences are available upon request.
Northern Blot Analysis. Total RNA was isolated from EBs, and Northern blot analysis was performed with 20 g of total RNA. 32 P-radiolabeled riboprobes were transcribed from Flk1, Jagged1, and ␤-actin cDNAs. The hybridization was done in 60% (vol͞vol) Formamide͞5ϫ SSC͞5ϫ Denhardt's solution (0.02% polyvinylpyrrolidone͞0.02% Ficoll͞0.02% BSA)͞1% SDS͞20 mM NaH 2 PO 4 (pH 6.8)͞0.1 mg/ml salmon sperm DNA͞100 mg/ml yeast tRNA͞10 mg/ml poly(A) ϩ mRNA͞7% (vol͞vol) dextran sulfate for 14 h at 65°C. Washes were performed at room temperature with 2ϫ SSC and 1% SDS at 50°C for 15 min each, followed by a 2-h wash at 80°C with 0.2ϫ SSC and 1% SDS.
Hematopoietic Colony Assay. Individual yolk sacs from 9.5 dpc Tie1-lacZ and Flk1͞int-3 embryos were treated with 0.5 ml of 0.1% collagenase͞0.45% dispase͞20% (vol͞vol) FCS in PBS for 1 h at 37°C as described (28) . The cells were then plated in 2 ml of 1.0% methylcellulose in Iscove's modified Dulbecco's medium (IMDM) supplemented with 15% (vol͞vol) FCS͞100 M 2-mercaptoethanol͞2 mM L-glutamine͞1% BSA͞10 g/ml pancreatic insulin͞200 g/ml human transferrin͞3 units/ml erythropoietin͞10 ng/ml IL-3͞10 ng/ml IL-6͞50 ng͞ml stem cell factor (Methocult GF M3434, StemCell Technologies, Vancouver). Colonies were incubated in a humidified CO 2 atmosphere at 37°C and scored visually at day 10.
Results
Generation of Flk1͞int-3 ES Cells. We have established that deletion of the extracellular domain of Notch4 results in a constitutively active Notch protein, which we will term Notch4(int-3) (29) . By using a ''knockin'' strategy, we introduced Notch4(int-3) into the Flk1 locus in such a manner that the endogenous gene was mutated and replaced by Notch4(int-3). This replacement should have resulted in expression of Notch4(int-3) in an endothelial-specific manner. To provide a marker of endothelial development, targeting was performed in two different parental ES-cell lines (1D5 and 1D10) that are heterozygous for a targeted insertion of lacZ into the Tie1 locus (ref. 30 ; Fig. 1 A) . Clones were isolated from parental ES-cell lines after selection and were genotyped for homologous recombination by Southern blotting (Fig. 1C) . Of 243 clones, 9 were correctly targeted; for further analysis, 2 from each parental line were used (2G6 and 1A12 from 1D5; 5C9 and 5F1 from 1D10).
The Notch4(int-3) cDNA encodes an HA epitope at the carboxyl terminus and has identical activity as nontagged Notch4(int-3) (29) . To demonstrate that Notch4(int-3) transcripts are expressed in the ES-cell lines, RT-PCR using Notch4(int-3) and HA-specific primers was performed on ES-cell RNA and RNA from EBs. Expression of Notch4(int-3) transcripts was observed only in EBs derived from ES cells after homologous recombination and was not seen in control EBs (Fig. 1D) . All further experiments were done by using four independently generated ES-cell lines (2G6, 1A12, 5C9, and 5F1) and two parental ES-cell lines (1D5 and 1D10), and resulted in consistent and reproducible phenotypes. Unless otherwise specified, we will refer to the four ES-cell lines that were generated by homologous recombination as Flk1͞int-3, and refer to the two parental ES-cell lines as Tie1-lacZ. Restricted and Disorganized Vasculature. Flk1͞int-3 and control Tie1-lacZ ES-cell lines were aggregated with tetraploid wild-type embryos (Fig. 1 A) and transferred into pseudopregnant recipients. The tetraploid cells failed to contribute to embryonic tissues such that aggregation of ES cells and a tetraploid embryo produced a conceptus in which the entire embryo, as well as the mesoderm of the yolk sac, was wholly ES-cell derived (31) . The vasculature in Flk1͞int-3 and Tie1-lacZ embryos was visualized by ␤-galactosidase staining in both whole mounts (Fig. 2) and histological sections of embryos (Fig. 3) . At 8.5 dpc, Flk1͞int-3 embryos appeared morphologically normal, and the vascular plexus in embryos and yolk sacs appeared identical to control Tie1-lacZ embryos (data not shown). By 9.5 dpc, Flk1͞int-3 embryos were growth and developmentally delayed (Fig. 2 B and D) and died soon thereafter (between 9.5 and 10.5 dpc), presumably because of vascular problems. The extent of the developing vasculature in Flk1͞int-3 embryos was restricted, fewer small vessels were seen, and vascular networks were disorganized. Major blood vessels such as the dorsal aorta, cardinal veins, intersomitic arteries, and arteries in the brain were present in mutant embryos (Fig. 2 B and D) , suggesting that the initial stages of vascular development occurred in Flk1͞int-3 embryos. However, the fine, tree-like vascular networks observed in the brains of control Tie1-lacZ embryos (Fig. 2 A and C) failed to form in Flk1͞int-3 embryos (Fig. 2 B and D) . Instead, disorganized and dilated vessels were observed, and vessels in the brain periphery either did not develop or degenerated.
Sagittal sections made through the heads of Flk1͞int-3 embryos confirmed the absence of small branching vessels and the persistence of large dilated vessels. The vessel wall integrity of these dilated vessels was often lost, and large areas of necrosis were seen in mutant embryos (Fig. 3B) . The hearts in the Flk1͞int-3 embryos Fig. 2 . Embryo whole-mounts composite. Control Tie1-lacZ (A and C) and Flk1͞int-3 (B and D) embryos at 9.5 dpc were processed for whole-mount ␤-galactosidase staining to visualize the endothelial cells. At 9.5 dpc, vasculature in mutant embryos appears to be more restricted and disorganized. Yolk-sac vasculature is shown for Tie1-lacZ (E) and Flk1͞int-3 (F). Analysis of vessels in the umbilical cord (arrow) is shown for Tie1-lacZ (G) and Flk1͞int-3 (H). appeared relatively normal, although enlarged and normal heart looping and trabeculation were observed (Fig. 3D) , suggesting that Flk1͞int-3 embryos do not die because of heart defects.
The yolk-sac vasculature was abnormal in Flk1͞int-3 embryos. The honeycomb vascular plexus formed normally at 8.5 dpc, but was largely unchanged across most of the surface of the yolk sac at 9.5 dpc (Fig. 2F) . The major vitelline vessels associated with the connection between the yolk sac and the embryo were formed, however, and were actually enlarged in caliber (Fig. 2H) . As development proceeded, the vasculature of the yolk sacs of mutants appeared to degenerate in a gradient, beginning at the periphery and ending with the area where the major yolk-sac vessels connect the sac and the embryo (data not shown). This observation is similar to the observed degeneration in the brain vascular plexus.
Is There a Vascular Remodeling Defect in Flk1͞int-3 Embryos?
The phenotype observed in Flk1͞int-3 embryos is superficially similar to the vascular-remodeling defects observed in Tie2 mutants and in embryos overexpressing its negatively acting ligand, Ang2 (32) . We investigated possible interactions between the Tie and Notch pathways in these embryos.
Other reports show that mice that are singly heterozygous for either Flk1 (23) or Tie1 (30) are normal. The strategy used to generate the Flk1͞int-3 embryos involved knocking out one allele of Flk1 in a background heterozygous for a targeted mutation of Tie1. The embryos were thus doubly heterozygous for Flk1 and Tie1 mutations. To test whether the doubly heterozygous genotype alone resulted in a vascular phenotype, Flk1 ϩ/Ϫ mice were crossed with Tie1 ϩ/Ϫ mice, and the offspring were genotyped. In the two litters (22 embryos) examined, the produced genotypes reflected the normal Mendelian ratios, showing that doubly heterozygous animals for Flk1 and Tie1 were normal.
It is possible that Notch signaling directly affected expression of Tie genes, leading to the phenotypic effects. Clearly, this was not true for Tie1, because the Tie1-lacZ allele was normally expressed in the endothelium of the developing embryos. However, Tie1 seems to be involved with later development of the microvasculature and is not likely to be involved in the early events seen here. We then examined expression of Tie2 by whole-mount RNA in situ and found that its expression was unaffected (Fig. 4 A and B) . This finding suggested that Notch signaling might be involved in vascular remodeling downstream of Tie2 signaling. The major defect seen in mutants in the Ang͞Tie2 pathway was a failure of recruitment of perivascular cells to the developing blood vessels. To test this supposition, we examined the expression of SMA, a marker of perivascular cells. SMA antibody staining revealed that there was some recruitment of accessory cells to the abnormally developing vessels in the transgenic embryos, although the extent of SMA staining was reduced concomitantly with the reduction in the vasculature (Fig. 4 C and D) . SMA antibody staining of embryo sections also showed staining of perivascular cells associated with both major vessels and the dorsal aorta (Fig. 4 E and F) .
The defects seen are also potentially similar to the phenotype of Jagged1 loss-of-function mutations. We examined expression of Jagged1 in the embryos and observed a down-regulation of expression (Fig. 4 G and H) , suggesting that there may be a feedback between activation of Notch signaling and expression of appropriate ligands, as seen in several other situations where Notch signaling is active.
Flk1͞int-3 EBs Develop Abnormal Vascular Arrays.
Examination of the phenotype of Flk1͞int-3 embryos suggested that the effect is somehow involved in the basic patterning rather than in the process of vessel stabilization during development. If this is true, we would expect to observe a phenotype even during differentiation of ES cells in vitro, where primitive endothelial tubes, but not mature blood vessels with associated cells, can develop. EBs were generated from the control Tie1-lacZ͞ϩ and Flk1͞int-3 ES-cell lines. The vascular networks observed in EBs (derived from Flk1͞int-3 ES cells) were disorganized and did not form the fine-caliber vessels observed in control EBs (Fig. 5A) . Instead, the vessels were large and often clumped together, without the extensive branching seen in the controls. This defect was apparent despite the continued expression of several markers of endothelial development, including Tie1, Flk1, Notch3, Notch4, and Jagged1 (Fig. 5 B and C) . Northern blot analysis of EBs did not reveal significant changes in Jagged1 expression (Fig. 5C ) in contrast to Jagged1 levels analyzed by whole-mount in situ hybridization of mutant embryos (Fig. 4 E  and F) . These data suggest that this phenotype is the result of an inherent defect in endothelial cells that express a constitutive activated Notch4 protein, and that the expression of activated Notch4 disrupts the development of vascular networks.
Hematopoietic Development Is Not Affected in Flk1͞int-3 Embryos.
Flk1 is expressed early enough in development to be a marker of the putative common precursor of the endothelial and the hematopoietic system, the hemangioblast. Thus, expression of activated Notch under the Flk1 promoter might affect allocation of the progeny of the hemangioblast to the endothelial vs. the hematopoietic lineages, if this decision is under Notch control. We examined the development of hematopoietic stem cells in the genetically altered embryos. Histological sections made through control and Flk1͞int-3 embryos revealed the presence of hematopoietic cells within the lumen of the blood vessels ( Fig. 3 E and F) , showing that hematopoiesis had not been completely suppressed. We then measured the extent of hematopoiesis by in vitro colony assay (Table 1 ) by using yolk-sac cells of 9.5 dpc embryos. Tie1-lacZ-and Flk1͞int-3-derived yolksac cells produced equivalent numbers of erythroid and macrophage colonies, suggesting that expression of Notch4(int-3) in early hematopoietic cells does not perturb their development.
Discussion
Vascular development is a complex process controlled by many different signaling pathways. By expressing an activated form of the Notch4 gene specifically in endothelial cells, we have demonstrated that this pathway is likely to play an intrinsic role in endothelial cells by regulating branching morphogenesis and patterning the developing vasculature.
Expression of Notch4(int-3) under the regulatory elements of the Flk1 gene will lead to expression in the common precursors of the endothelial and hematopoietic lineages, the so-called hemangioblasts. We did not observe overt deficiencies of hematopoietic precursors in the Flk1͞int-3 embryos, and early development of the endothelium appeared normal. This observation suggests that Notch4 signaling does not regulate the early cell-fate decision to become hematopoietic or endothelial. This observation does not preclude a later role for Notch signaling in cell-fate decisions within the hematopoietic lineages. Indeed, there is good evidence that Notch signaling pathways are involved in cell-fate specification within the T cell lineage (12) . Notch-family proteins can display distinct signaling activities (33) ; thus, it may be that activation of other Notch pathways may be important in regulating lineage decisions in the hemangioblast.
Phenotypic effects were first observed in the vasculature of Flk1͞int-3 embryos around 9.5 dpc, at the time when vascular remodeling occurs (3). However, it does not seem that the defect is in the vessel stabilization pathway regulated by the Angiopoietin͞Tie pathway. Supporting cells that expressed SMA were recruited to the abnormal vessels of Flk1͞int-3 embryos, and both Tie receptors apparently were normally expressed in the endothelium. When ES cells differentiate in vitro into EBs, endothelial cells develop and undergo the initial stages of vasculogenesis, vessel formation, and patterning. However, these vessels do not undergo Colonies were visually scored at day 10 of culture. The mean number of colonies was not significantly different between the Tie1-lacZ and Flk1͞int-3 yolk sacs (P Ͼ 0.2, P Ͼ 0.2, P Ͼ 0.5, respectively). vascular remodeling and stabilization. Because the blood vessels developing in Flk1͞int-3 EBs apparently show vascular defects similar to the embryos (namely, failure of fine branching morphogenesis and enlarged primary vessels), it seems that activation of the Notch4 pathway is acting intrinsically in the endothelial lineage to affect the primary patterning of the vessels.
The defects in the Flk1͞int-3 embryos suggest that Notch4 may normally regulate branching morphogenesis in the developing vasculature. When activated ubiquitously in the endothelial lineage under the Flk1 promoter, Notch4 signaling leads to a major block in fine branching of the vasculature, suggesting that it regulates the branching phase of vascular development. Temporally and spatially localized activation of the Notch signaling pathway could thus play an important role in normal development by establishing the final pattern of vascular branching seen in both embryos and yolk sacs. That Notch signaling has a role in the regulation of branching morphogenesis is consistent with observations in other systems. The int-3 oncogene, the activated Notch used here, leads to mammary tumorigenesis. However, its initial effect is to block epithelial branching in the mammary gland (34) . We have also shown that activated Notch blocks branching morphogenesis induced by hepatocyte growth factor in mammary epithelial cultures in vitro (29) . Recent studies have implicated Notch in tracheal branching in Drosophila (35) and in neurite branching in the mammalian nervous system (36) .
Our interpretation of the Flk1͞int-3 phenotype would suggest that gain-of-function mutations of Notch proteins in the endothelial lineage would lead to loss of fine branching, whereas loss-offunction mutations would lead to excessive branching. The recent loss-of-function mutation in Jagged1 in mice does not necessarily seem to fit this hypothesis, because the images presented of the mutant embryos show an absence of smaller vessels similar to that reported here in the gain-of-function case. However, it is not known whether the vascular defects seen in Jagged1 mutants are caused by a primary or a secondary effect on the endothelium. There are added complications in all these analyses that are brought about by the complex feedback loops that control expression of the genes of the Notch pathway. The expression of Jagged1 seems to be downregulated in the Flk1͞int-3 embryos, which could explain the similarity between the two phenotypes. Resolution of this complexity will require an analysis of mutants in different components of the pathway, especially those generated in a tissue-specific manner, where the influence of indirect effects of Notch signaling caused by its action in multiple lineages can be excluded. The strategy we used to activate Notch in embryonic vasculature may not directly address the normal role of Notch in development, but it proved to be informative. A recent analysis of Notch1 mutant embryos and Notch1͞Notch4 doubly mutant embryos showed that loss of Notch expression can also lead to vascular remodeling defects and abnormal vascular patterning (19) . This phenotype is somewhat similar to that seen in Flk1͞int-3 mutant embryos. One point of contrast is the dilated vessels in the Flk1͞int-3 embryos as opposed to the collapsed vessels seen in Notch1͞Notch4 double mutants (19) , again suggesting a role for Notch signaling in regulating vessel size, patterning, or integrity.
Because activated Notch blocks vessel branching in the embryo, it will be important to determine whether the Notch pathway is also involved in neovascularization in the adult and in pathological settings, such as tumor angiogenesis.
